Pharma sector calls for drug prices to build in real-world value
The pharmaceutical industry wants future negotiations on drug pricing to include the extent to which drugs prevent costly hospital stays and details of other societal benefits they generate
The pharmaceutical industry wants future negotiations on drug pricing to include the extent to which drugs prevent costly hospital stays and details of other societal benefits they generate.
Aidan Lynch, general manager of GSK and president of the Irish Pharmaceutical Healthcare Association (IPHA), which represents the industry, said: “If we could look, not just at price in isolation, but at an end-to-end cost, such as bed days and reduced staff required – that type of...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Specialist eating disorder unit delayed until at least mid-2022
A new unit at Mount Carmel Hospital in Dublin was due to open by the end of the year
Updated cost of new children’s hospital still ‘confidential’
Department of Health refuses to disclose costs associated with the project to Public Accounts Committee despite speculation that price could reach €2bn
Hospital group boards to be disbanded to make way for regional health areas
Boards are informed of imminent Sláintecare change by letter as their extended term of office expires
St Vincent’s set to build new €15m intensive care unit
Hospital’s ICU capacity has operated under ‘unsustainable pressure’ since the onset of the Covid-19 pandemic, says its director of operations